Syndax Pharmaceuticals (SNDX) Revenue: 2015-2020
Historic Revenue for Syndax Pharmaceuticals (SNDX) over the last 5 years, with Dec 2020 value amounting to $380,000.
- Syndax Pharmaceuticals' Revenue changed negligibly% to $380,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $1.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $23.7 million for FY2024, which is 11484.62% up from last year.
- Syndax Pharmaceuticals' Revenue amounted to $380,000 in Q4 2020, which was up 0.26% from $379,000 recorded in Q3 2020.
- Syndax Pharmaceuticals' Revenue's 5-year high stood at $1.2 million during Q4 2017, with a 5-year trough of $305,000 in Q1 2016.
- Its 3-year average for Revenue is $379,250, with a median of $379,000 in 2020.
- Per our database at Business Quant, Syndax Pharmaceuticals' Revenue spiked by 291.15% in 2017 and then crashed by 68.15% in 2018.
- Syndax Pharmaceuticals' Revenue (Quarterly) stood at $305,000 in 2016, then spiked by 291.15% to $1.2 million in 2017, then slumped by 68.15% to $380,000 in 2018, then remained steady at $380,000 in 2019, then remained steady at $380,000 in 2020.
- Its Revenue was $380,000 in Q4 2020, compared to $379,000 in Q3 2020 and $379,000 in Q2 2020.